Figure 3
From: Characterizing pre-dialysis care in the era of eGFR reporting: a cohort study
Quality of care delivered to CKD 3b-4 patients.
Pre-eGFR cohort: n=274, Post-eGFR cohort: n=266.
†Pre-eGFR/PCP vs. Post-eGFR/PCP, P=0.07; Pre-eGFR/PCP vs. Pre-eGFR/Co, P=0.01; PosteGFR/ PCP vs. Post-eGFR/Co, P=0.003.
CKD chronic kidney disease documentation, ACEI/ARB angiotensin converting enzyme inhibitor or angiotensin receptor blocker use, NSAID non-steroidal anti-inflammatory drug, Ualb quantitative urinary albumin testing, eGFR estimated glomerular filtration rate, PCP primary care physician managed, Co co-managed.